期刊文献+

高效液相色谱法测定帕潘立酮的含量及有关物质 被引量:3

Determination of related substances and content of paliperidone by HPLC
在线阅读 下载PDF
导出
摘要 目的建立测定帕潘立酮含量和有关物质的高效液相色谱法。方法采用C18色谱柱(4.6mm×150mm,5μm),以0.1mol/L磷酸氢二钾溶液(磷酸调节pH至7.0)-乙腈(70:30)为流动相,流速为1mL/min;检测波长为237nm,柱温为35℃。结果帕潘立酮峰与各杂质峰分离良好,在509~0.11μg/mL浓度范围内,帕潘立酮浓度与其峰面积呈良好的线性关系(r=0.9991,n=10);检测限、定量限分别为1ng和5ng;含量测定及有关物质检查的中间精密度RSD分别为0.09%(n=6)与4.58%(n=6)。结论该法简便、精密、专属、灵敏,可同时应用于帕潘立酮含量测定和有关物质检查。 Objective To develop an HPLC method for determining simultaneously the content and related substances of paliperidone for quality control. Methods The method was performed on a C18 column(4.6mm× 150mm, 5μm) with 0. l mol/L potassium dihydrogen phosphate (adjust pH to 7.0 by phosphoric acid)-acetonitrile(70:30)as the mobile phase.The flow rate was 1.0mL/min. The detection wavelength was 237nm, and the column temperature was maintained at 35 ℃. Results Paliperidone was completely separated from related substances.The calibration curve of paliperidone was linear(r=0.9991, n=10)with the range of 0.11-509μg/mL; quantitation limit and detection limit was lng and 5ng separately; the intermediate precision RSD were 0.09%, 4.58% (n=6) in content and related substance determination. Conclusion The method is simple, accurate, specific and sensitive for simultaneously determining content and related substances ofpaliperidone.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2013年第2期125-129,共5页 Chinese Journal of Antibiotics
关键词 帕潘立酮 含量 有关物质 高效液相色谱 Paliperidone Content determination Related substances HPLC
  • 相关文献

参考文献5

  • 1Carla M C,Ibrahim T,John J S. Efficacy and safety of paliperidone extended-release in schizophrenia patients with prominent affective symptoms[J].Journal of Affective Disorders,2010,(1-3):193-199.
  • 2Roberto C,Marta B,Carmelo G. 9-OH risperidone response in risperidone poor responders:An open study of drug response concordance[J].Neurol Psych Brain Res,2012,(03):109-113.
  • 3Rasparini,Ghisleri. A process for the purification of paliperidone[P].EP2343296 (A1),2011.
  • 4王超,禹艳坤,刘爱霞,冀亚飞.帕潘立酮的合成[J].中国医药工业杂志,2010,41(10):721-723. 被引量:8
  • 5国家药典委员会.中华人民共和国药典(第二部)[S]北京:化学工业出版社,2010附录205.

二级参考文献10

  • 1US FDA.FDA Approves New Drug for Schizophrenia[EB/OL].[2006-12-20].http://www.fda.gov/News-Events/ Newsroom/PressAnnouncernents/2006/ucm108812.htm.
  • 2Kankan RN,Rao DR,Pathi SL.Process for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes:WO,2009047499[P].2009-04-16.(CA 2009,150:423221).
  • 3Barti J,Benovsky E Krajcovic J.Synthesis of paliperidone:WO,2009074333[P].2009-06-18.(CA2009,151:56864).
  • 4Dolitzky BZ,Shapiro E,Ini S,et al.Process for the synthesis of CMHTP and intermediates thereof:US,20080214809[P].2008-09-04.(CA 2008,149:307878).
  • 5Bristol JA,Gross I,Lovey RG.An improved synthesis of 2-amino-3-alkyloxypyridines by a phase-transfer catalyzed ether synthesis[J].Synthesis,1981,(12):971-973.
  • 6Dehmlow EV.Advances in phase-transfer catalysis[J].Angew Chem Int EdEngl,1977,16 (8):493-505.
  • 7Ravi JRR,Pulla Reddy M,Adibhatla Kali Satya BR,et al.An improved,industrially viable process for the preparation of high purity paliperidone:WO,2009010988[P].2009-01-22.(CA2009,150:168378).
  • 8Ravi JRR,Pulla Reddy M,Adibhatla Kali Satya BR,et al.Stable polymorphic form of paliperidone and process for its preparation:WO,2009016653[P].2009-02-05.(CA 2009,150:199278).
  • 9王世辉,胡春.帕潘立酮(paliperidone)[J].中国药物化学杂志,2007,17(5):338-338. 被引量:6
  • 10管宜河,于小红,王希娟.抗精神病药利培酮的合成[J].化工生产与技术,2008,15(1):17-19. 被引量:8

共引文献7

同被引文献44

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部